CPH 0.00% 0.9¢ creso pharma limited

Ann: Trading Halt, page-46

  1. 914 Posts.
    lightbulb Created with Sketch. 394
    Might be the first one. The others don't quite fit the bill for a TH.

    Could be an TH associated with news of a dealers licence being granted, coupled with confirmation of execution of the 4 or so other Halucenex agreements with other parties?

    The dealer's licence will allow Halucenex to commence it's Phase 2 clinical trials but also produce, sell/export as well. So another potential revenue stream?

    https://hotcopper.com.au/data/attachments/3172/3172855-1c309e0ce8c3b5e388c65344e256a8f0.jpg



    Last edited by getbig: 12/05/21
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.